Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
boston blog main
boston top stories
life sciences
mylan
2
×
national blog main
national top stories
new york blog main
new york top stories
acorda therapeutics
adverum biotechnologies
albert bourla
alzheimer's disease
amgen
amicus therapeutics
ampyra
apokyn
apomorphine
arvinas
batten disease
bayer
biogen
biotech
boulder/denver blog main
boulder/denver top stories
breast cancer
brian stuglik
cancer diagnostics
cancer immunotherapy
casimir trials
celenex
christine mcsherry
chuck schumer
clinial trials
clinical trials
crispr therapeutics
cystic fibrosis
dalfampridine
dan chevallard
darolutamide
What
drug
patients
2
×
acorda
acquisitions
albert
approved
biggest
bio
bourla
ceo
company
cope
crispr
disease
episodes
fda
friday
future
gets
help
imports
late
looms
maker
maps
meant
measured
medications
new
nod
parkinson’s
pfizer
pfizer’s
revenue
rival
roundup
stop
today
treatment
working
Language
unknown
Current search:
mylan
×
patients
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
